Detailed comparison on parameters like NAV | Returns | Risk | Rating | Analysis
Risk | Very High | Very High |
Rating | 4.0 | 5.0 |
Min SIP Amount | ₹500 | ₹100 |
Expense Ratio | 1.76 | 1.42 |
NAV | ₹102.58 | ₹1841.39 |
Fund Started | 31 May 2007 | 08 Dec 1994 |
Fund Size | ₹12044.23 Cr | ₹66344.40 Cr |
Exit Load | Exit load of 1% if redeemed within 1 year | Exit load of 1% if redeemed within 1 year
|
Risk
Rating
Min SIP Amount
Expense Ratio
NAV
Fund Started
Fund Size
Exit Load
1 Year | 16.17% | 21.56% |
3 Year | 15.19% | 22.35% |
5 Year | 19.16% | 22.26% |
1 Year
3 Year
5 Year
Equity | 95.88% | 87.35% |
Cash | 3.91% | 11.88% |
Equity
Cash
Top 10 Holdings |
|
|
Top 10 Holdings
Name | Assets |
---|---|
HDFC Bank Ltd. | 10.02% |
ICICI Bank Ltd. | 8.86% |
Infosys Ltd. | 6.10% |
Axis Bank Ltd. | 5.60% |
Zomato Ltd. | 5.40% |
Bharti Airtel Ltd. | 5.21% |
Sun Pharmaceutical Industries Ltd. | 4.97% |
Reliance Industries Ltd. | 4.45% |
Cipla Ltd. | 4.41% |
PB Fintech Ltd. | 3.58% |
Name | Assets |
---|---|
HDFC Bank Ltd. | 9.75% |
ICICI Bank Ltd. | 9.71% |
Axis Bank Ltd. | 8.23% |
Cipla Ltd. | 4.44% |
Kotak Mahindra Bank Ltd. | 4.39% |
Maruti Suzuki India Ltd. | 4.18% |
SBI Life Insurance Company Ltd. | 4.07% |
Bharti Airtel Ltd. | 4.01% |
HCL Technologies Ltd. | 3.90% |
Piramal Pharma Ltd. | 2.94% |
Name | Varun Sharma | Dhruv Muchhal |
Start Date | 01 Sep 2023 | 14 Sep 2023 |
Name
Start Date
Description | The scheme seeks to achieve capital appreciation through investing predominantly in Indian companies/sectors with high growth rates or potential. | The scheme seeks to generate capital appreciation / income from a portfolio, predominantly invested in equity & equity related instruments. |
Launch Date | 31 May 2007 | 08 Dec 1994 |
Description
Launch Date